ArticleOncoTargets and therapy2017

Long-term survival after a favorable response to anti-EGFR antibody plus chemotherapy to treat bone marrow metastasis: a case report of

Sho Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.